首页> 外国专利> A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis

A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis

机译:一种具有生物活性的人酸性成纤维细胞生长因子的生产方法及其在促进血管新生中的应用

摘要

The gene of human acidic fibroblast growth factor 155 (haFGF 155) has been obtained by chemical synthesis. The nucleotide sequence of haFGF 155 gene has been deduced on the basis of haFGF 155 amino acid sequence as described in the literature. The amino acid sequence, of the synthesized haFGF 155 does not differ from those described in the literature. The nucleotide sequence of haFGF gene differs from those described previously. For chemical synthesis of haFGF 155 gene, codons were used which are the ones most often used by E. coli in highly expressed E. coli proteins. A plasmid with haFGF 155 (phaFGF 155) gene was obtained and was used to transform E. coli. Production of haFGF 154 protein was achieved by cultivation of the producer strain under conditions which slow down the lytic development of lambda phage. The haFGF 154 protein accumulated in culture medium in a soluble condition as a result of the producer strain cells lysis by the lambda phage. The haFGF 154 protein constituted 20% of the soluble protein accumulated in the culture medium and its biological activity was demonstrated by its ability to generate new vessels (angiogenesis). The initiator methionine residue at position 1 of the FGF 155 protein was completely removed during protein synthesis resulting in an FGF 154 amino acid product. The use of the phage-dependent method to produce other forms of the haFGF protein is also disclosed.
机译:人酸性成纤维细胞生长因子155(haFGF 155)的基因已经通过化学合成获得。如文献中所述,已经基于haFGF 155氨基酸序列推导了haFGF 155基因的核苷酸序列。合成的haFGF 155的氨基酸序列与文献中所描述的相同。 haFGF基因的核苷酸序列与先前描述的不同。为了化学合成haFGF 155基因,使用了密码子,这些密码子是大肠杆菌在高表达的大肠杆菌蛋白中最常用的密码子。获得具有haFGF 155(phaFGF 155)基因的质粒,并将其用于转化大肠杆菌。通过在减慢λ噬菌体的裂解发育的条件下培养生产菌株来实现haFGF 154蛋白的生产。由于生产菌菌株细胞被λ噬菌体裂解,haFGF 154蛋白以可溶的状态积聚在培养基中。 haFGF 154蛋白占培养基中累积的可溶性蛋白的20%,其生物学活性通过其产生新血管(血管生成)的能力得以证明。在蛋白质合成过程中,FGF 155蛋白质第1位的引发剂蛋氨酸残基被完全去除,从而得到FGF 154氨基酸产物。还公开了使用噬菌体依赖性方法产生其他形式的haFGF蛋白。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号